ProfileGDS4718 / 220282_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 33% 24% 36% 27% 29% 28% 33% 25% 29% 31% 32% 27% 23% 24% 25% 26% 26% 26% 27% 20% 28% 30% 24% 24% 29% 28% 23% 31% 26% 28% 25% 26% 35% 28% 26% 26% 27% 21% 32% 33% 27% 27% 26% 29% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]4.6794433
GSM549102patient 115, normal, homogenized [OPG study]4.3304224
GSM549104patient 119, normal, homogenized [OPG study]4.8135336
GSM549108patient 138, normal, homogenized [OPG study]4.4594927
GSM549119patient 077, normal, homogenized [OPG study]4.5165829
GSM549133patient 032, cancer, homogenized [OPG study]4.388428
GSM549139patient 042, cancer, homogenized [OPG study]4.6602833
GSM549099patient 107, normal, homogenized [OPG study]4.3403425
GSM549109patient 139, normal, homogenized [OPG study]4.5147129
GSM549110patient 046, normal, homogenized [OPG study]4.5745331
GSM549114patient 063, normal, homogenized [OPG study]4.565232
GSM549122patient 082, normal, homogenized [OPG study]4.4363927
GSM549134patient 033, cancer, homogenized [OPG study]4.2601323
GSM549136patient 036, cancer, homogenized [OPG study]4.232224
GSM549140patient 044, cancer, homogenized [OPG study]4.2829125
GSM549111patient 047, normal, homogenized [OPG study]4.3388626
GSM549113patient 057, normal, homogenized [OPG study]4.3359826
GSM549132patient 031, cancer, homogenized [OPG study]4.3690726
GSM549137patient 038, cancer, homogenized [OPG study]4.4065327
GSM549142patient 047, cancer, homogenized [OPG study]4.2477220
GSM549100patient 110, normal, homogenized [OPG study]4.4582328
GSM549107patient 135, normal, homogenized [OPG study]4.5213230
GSM549115patient 068, normal, homogenized [OPG study]4.242624
GSM549116patient 072, normal, homogenized [OPG study]4.2867424
GSM549120patient 078, normal, homogenized [OPG study]4.5067629
GSM549131patient 030, cancer, homogenized [OPG study]4.4123628
GSM549118patient 074, normal, homogenized [OPG study]4.2436923
GSM549129patient 027, cancer, homogenized [OPG study]4.61331
GSM549123patient 088, normal, homogenized [OPG study]4.3462326
GSM549124patient 006, cancer, homogenized [OPG study]4.4861328
GSM549126patient 015, cancer, homogenized [OPG study]4.3414225
GSM549128patient 025, cancer, homogenized [OPG study]4.3427626
GSM549103patient 117, normal, homogenized [OPG study]4.8283735
GSM549117patient 073, normal, homogenized [OPG study]4.4176528
GSM549138patient 041, cancer, homogenized [OPG study]4.3449526
GSM549141patient 045, cancer, homogenized [OPG study]4.3143126
GSM549130patient 028, cancer, homogenized [OPG study]4.4310727
GSM549101patient 111, normal, homogenized [OPG study]4.2010521
GSM549105patient 128, normal, homogenized [OPG study]4.6654432
GSM549106patient 134, normal, homogenized [OPG study]4.6286233
GSM549112patient 048, normal, homogenized [OPG study]4.4092527
GSM549125patient 011, cancer, homogenized [OPG study]4.4394327
GSM549127patient 024, cancer, homogenized [OPG study]4.3673926
GSM549135patient 035, cancer, homogenized [OPG study]4.4327429